학술논문
Limited Benefit from the Addition of Immunotherapy to Chemotherapy in TKI-Refractory EGFR-Mutant Lung Adenocarcinoma
Document Type
Article
Author
Source
In: Cancers . (Cancers, July 2022, 14(14))
Subject
Language
English
ISSN
20726694